LXRX Financial Facts
Collaborative research: 27.69MInterest expense: -1.65M
See Full Income Statement
Other assets: 454K
Total liabilities: 331.76M
See Full Balance Sheet
Lexicon Pharmaceuticals, Inc. (LXRX) Earnings
|
Expand Research on LXRX
| Next EPS Date | 11/11/26 | EPS Growth Rate | -50.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +36.4% | Revenue Growth Rate | -78.9% |
| Average % Move 1-Wk after EPS | +12.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | -$0.06 | N/A | N/A | $2.97M | N/A | N/A | N/A | ||
| 8/6/26 |
Q226 | -$0.07 | -$0.05 | -$0.02 | $28.9M | $4M | N/A |  | | Details | |
| 5/7/26 | Q126 | $0.00 | -$0.04 | +$0.04 | $21.1M | $9.78M | N/A | | | Details | |
| 5/4/26 |
Q126 | N/A | -$0.04 | N/A | N/A | $9.78M | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$0.04 | N/A | N/A | $9.78M | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$0.04 | N/A | N/A | $9.78M | N/A | N/A | N/A | ||
| 3/5/26 | Q425 | -$0.04 | -$0.07 | +$0.03 | $5.5M | $3.92M | N/A | | | Details | |
| 10/30/25 |
Q325 | N/A | -$0.07 | N/A | N/A | $4.65M | N/A | N/A | N/A |
